Quantifying Weight Loss Prior to Pancreatic Cancer Diagnosis: A Systematic Review and Meta-Analysis
Researchers quantified pre-diagnosis weight loss in pancreatic cancer, improving how doctors can spot warning signs earlier.
Meta-analysis of 25 studies (n=25,971) quantified pre-diagnostic weight loss in pancreatic cancer at a mean of 5.9 kg, with significant heterogeneity partly explained by diabetes status, weight loss timing, and whether weight loss was self-reported. The authors provide a quantitative reference for pre-diagnostic weight loss that may improve the specificity of early detection algorithms for pancreatic cancer.
What the study was
- Study design
- Systematic review + meta-analysis (25 studies; PROSPERO registered)
- Population
- Pancreatic cancer patients pre-diagnosis (25 studies, 25,971 participants)
- Sample size
- 25971
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Cancer Med
Why it surfaced
Large meta-analysis (n=25,971) providing the first pooled quantitative reference for pre-diagnosis weight loss in pancreatic cancer; directly applicable to early detection model development for this high-mortality malignancy.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.